These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6601266)

  • 21. Therapy of acute otitis media caused by Branhamella catarrhalis. Preliminary report.
    Shurin PA; Van Hare GF
    Drugs; 1986; 31 Suppl 3():122-4. PubMed ID: 3488191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current status of bacterial resistance in the otolaryngology field: results from the Second Nationwide Survey in Japan.
    Suzuki K; Nishimura T; Baba S
    J Infect Chemother; 2003 Mar; 9(1):46-52. PubMed ID: 12673407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activity of amoxicillin plus clavulanic acid against Haemophilus influenzae and Branhamella catarrhalis.
    Liljequist BO; Gezelius L
    Eur J Clin Microbiol; 1986 Dec; 5(6):615-21. PubMed ID: 3492374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trimethoprim-sulfamethoxazole in the treatment of otitis media caused by ampicillin-resistant strains of Haemophilus influenzae.
    Schwartz RH; Rodriguez WJ; Khan WN; Mann R; Barsanti RG; Ross S
    Rev Infect Dis; 1982; 4(2):514-6. PubMed ID: 6981169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occurrence and transfer of ampicillin resistance associated with ampicillin-resistant Haemophilus influenzae isolated from a case at a day-care centre.
    Bysjö E; Dornbusch K
    Scand J Infect Dis; 1977; 9(4):293-6. PubMed ID: 341294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of nasopharyngeal cultures for bacteriologic assessment of acute otitis media in children.
    Gehanno P; Lenoir G; Barry B; Bons J; Boucot I; Berche P
    Pediatr Infect Dis J; 1996 Apr; 15(4):329-32. PubMed ID: 8866802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute otitis media caused by ampicillin-resistant Haemophilus influenzae type B.
    Crosson FJ; Watson WC; Bailey DW; MacLowry JD
    JAMA; 1976 Dec; 236(24):2778-9. PubMed ID: 1086911
    [No Abstract]   [Full Text] [Related]  

  • 28. Increasing antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Finland.
    Manninen R; Huovinen P; Nissinen A
    J Antimicrob Chemother; 1997 Sep; 40(3):387-92. PubMed ID: 9338492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections.
    Hoban D; Felmingham D
    J Antimicrob Chemother; 2002 Sep; 50 Suppl S1():49-59. PubMed ID: 12239228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secretory otitis media: microbiology of the middle ear and the nasopharynx.
    Kamme C; Nilsson NI
    Scand J Infect Dis; 1984; 16(3):291-6. PubMed ID: 6387891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency of Alloicoccus otitidis, Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae in children with otitis media with effusion (OME) in Iranian patients.
    Khoramrooz SS; Mirsalehian A; Emaneini M; Jabalameli F; Aligholi M; Saedi B; Bazargani A; Taherikalani M; Borghaei P; Razmpa E
    Auris Nasus Larynx; 2012 Aug; 39(4):369-73. PubMed ID: 21868180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute otitis media in Sweden. Role of Branhamella catarrhalis and the rationale for choice of antimicrobial therapy.
    Lundgren K; Ingvarsson L
    Drugs; 1986; 31 Suppl 3():125-31. PubMed ID: 3488192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preliminary serologic evidence for a pathogenic role of Branhamella catarrhalis.
    Leinonen M; Luotonen J; Herva E; Valkonen K; Mäkelä PH
    J Infect Dis; 1981 Dec; 144(6):570-4. PubMed ID: 7328328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Causative pathogens, antibiotic resistance and therapeutic considerations in acute otitis media.
    Block SL
    Pediatr Infect Dis J; 1997 Apr; 16(4):449-56. PubMed ID: 9109158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbiology of bacteria causing recurrent acute otitis media (AOM) and AOM treatment failure in young children in Spain: shifting pathogens in the post-pneumococcal conjugate vaccination era.
    Pumarola F; Marès J; Losada I; Minguella I; Moraga F; Tarragó D; Aguilera U; Casanovas JM; Gadea G; Trías E; Cenoz S; Sistiaga A; García-Corbeira P; Pirçon JY; Marano C; Hausdorff WP
    Int J Pediatr Otorhinolaryngol; 2013 Aug; 77(8):1231-6. PubMed ID: 23746414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenoxymethylpenicillin and therapeutic failure in acute otitis media.
    Laurin L; Prellner K; Kamme C
    Scand J Infect Dis; 1985; 17(4):367-70. PubMed ID: 3937232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The antibiotic susceptibilities and beta-lactamase production of clinical isolated Branhamella catarrhalis from acute otitis media in children.
    Suzuki K; Baba S; Inagaki M; Kobayashi T
    Auris Nasus Larynx; 1988; 15(2):105-11. PubMed ID: 3144965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenicity of and beta-lactamase production by Branhamella (Neisseria) catarrhalis.
    Percival A; Corkill JE; Rowlands J; Sykes RB
    Lancet; 1977 Dec; 2(8049):1175. PubMed ID: 73082
    [No Abstract]   [Full Text] [Related]  

  • 39. [Nasopharyngeal and middle ear flora in children with acute otitis media].
    Zielnik-Jurkiewicz B; Kolczyńska M
    Otolaryngol Pol; 2005; 59(4):537-42. PubMed ID: 16273858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-lactamase production and bacterial tolerance in recurrent acute otitis media.
    Roos K; Lind L; Holm SE
    Int J Pediatr Otorhinolaryngol; 1991 Apr; 21(2):155-61. PubMed ID: 1909690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.